Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Warren currently holds 252,876 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Warren has been a net seller of ESPR stock. They have purchased $7.5K and sold $2.7M worth of shares.
Eric Warren's most recent insider trade was on Jun 26, 2026, when they sold 104,124 shares at $0.00 per share.
Eric Warren serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 27 insider transactions totaling $2.8M over their tenure at the company.
Eric Warren holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Eric Warren has shown a selling trading pattern, with $7.5K in total purchases and $2.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Warren was on Jun 26, 2026, when they sold $2.7M worth of MLYS shares. This transaction involved 104,124 shares at $25.90 per share.
Eric Warren currently owns 252,876 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Warren's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Warren has 27 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for Eric Warren and 40,000+ other insiders.